Filing Details

Accession Number:
0001209191-20-062937
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-11 16:22:33
Reporting Period:
2020-12-09
Accepted Time:
2020-12-11 16:22:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1679082 Myovant Sciences Ltd. MYOV Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1712069 Matthew Lang C/O Myovant Sciences Inc.
2000 Sierra Point Parkway, 9Th Floor
Brisbane CA 94005
General Counsel & Corp. Secy. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2020-12-09 600 $7.78 146,465 No 4 M Direct
Common Shares Disposition 2020-12-09 600 $25.08 145,865 No 4 S Direct
Common Shares Acquisiton 2020-12-10 19,400 $7.78 165,265 No 4 M Direct
Common Shares Disposition 2020-12-10 19,400 $25.20 145,865 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Stock Option (Right to Buy) Disposition 2020-12-09 600 $0.00 600 $7.78
Common Shares Stock Option (Right to Buy) Disposition 2020-12-10 19,400 $0.00 19,400 $7.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
279,400 2027-07-16 No 4 M Direct
260,000 2027-07-16 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 trading plan.
  2. The shares were sold at prices ranging from $25.07 to $25.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares were sold at prices ranging from $25.05 to $25.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Fully vested.